The influence of paclitaxel in drug-drug interaction via hepatic organic anion transporter
Not Applicable
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000032370
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Severe complication (e.g., uncontrollable diabetis mellitus, liver disease) 2) Serological positive for HBs-antigen or HCV-antibody 3) Active synchronous cancer 4) Severe psychiatric disorder 5) Pregnant or lactating women, or men and women without wanting pregnancy 6) Severe hypersensitivity to medicine 7) Patients who were judged inappropriate for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma concentrations of endogenous substrates for OATP before and after paclitaxel administration
- Secondary Outcome Measures
Name Time Method